Hematologic Malignancies
Article
Impact of Pharmacist-Driven Telemedicine Services in Hematopoietic Stem Cell Transplant (HSCT) Long-term Care Clinic in a Veteran Population
Article
Evaluating the Incidence of Febrile Neutropenia and the Appropriate Use of Prophylactic Granulocyte Colony Stimulating Factors in Veterans Who Received Treatment for Non- Hodgkin’s Lymphoma
Article
A Rare Case of HHV8+ Multicentric Castleman Disease Presenting as Dermatitis
Original Research
Agent Orange Exposure, Transformation From MGUS to Multiple Myeloma, and Outcomes in Veterans
This study explored variation in survival related to Agent Orange exposure, transformation from MGUS to multiple myeloma, and survival as a...
News
Fewer transplants for MM with quadruplet therapy?
Findings bode well for quadruple drug therapy in treating newly diagnosed multiple myeloma.
Case Reports
Nodular Sclerosing Hodgkin Lymphoma With Paraneoplastic Cerebellar Degeneration
An atypical case of a young adult female patient with slow progressive onset of paraneoplastic cerebellar degeneration symptoms was diagnosed and...
Case Reports
Approach to Pancytopenia in a Deployed Service Member
Background: Pancytopenia is a result of increased destruction or decreased production of bone marrow cells and has a broad...
Case Reports
Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple Myeloma
In patients with multiple myeloma, thrombotic microangiopathy is a rare adverse event associated with proteasome inhibitors, such as bortezomib,...
Conference Coverage
‘Extremely exciting’ study results guide MM treatment options
New trial data help inform the tailoring of effective treatment approaches for patients with newly diagnosed multiple myeloma (MM).
Conference Coverage
Novel COVID-19 vaccine could fill the void for patients with blood cancers
Existing vaccines provide weak protection for immunocompromised patients with B-cell deficiencies.